Skip to content
HIPAA Risk Analysis

A HIPAA risk analysis your board can defend.

Valentra Labs runs the HIPAA Security Rule risk analysis as a continuous program — assets, risks, controls, and evidence in one operating record, not a once-a-year spreadsheet.

Program Assessment See How Valentra Works
The problem

A point-in-time risk analysis cannot answer what changed.

A HIPAA risk analysis that lives in a spreadsheet goes stale the day it is signed. When an auditor or the board asks what changed since, most teams cannot answer from a single source.

The gap is not the analysis. It is the operation behind it.

  • 01 / 03 The spreadsheet is accurate the day it is signed and stale the day after.
  • 02 / 03 No single record ties each risk to the control that treats it and the evidence behind it.
  • 03 / 03 When the board asks what changed since the last analysis, the answer lives in email threads, not a system.

Insight

Insight
A risk analysis is not a document you produce once. It is a state you maintain.

The Valentra operating principle

The Valentra approach

The Valentra approach: a risk analysis you operate.

Valentra Labs operates the risk analysis inside the Managed Security Program: Valentra Nexus discovers assets, ranks risk, ties each risk to a control and its evidence, and surfaces a board-ready Decision Packet leadership can act on.

  • Valentra Nexus discovers the assets in scope and ranks each risk by likelihood and impact.
  • Every risk carries the control that treats it and the evidence that proves the control runs.
  • Changes are tracked over time, so “what changed since” is answerable from one record.
  • A board-ready Decision Packet summarizes current posture, open risk, and the recommended action.
Outcome

What leadership gets a position you can defend, continuously

  • 01 / 03 A risk analysis that is current, not annual.
  • 02 / 03 Evidence tied to every control an auditor asks about.
  • 03 / 03 A Decision Packet the board can act on without a translation layer.
The difference

Same category. Different model.

Traditional risk analysis

A document delivered once

  • Produced by an outside firm, then handed back as a report.
  • Reflects the environment on the assessment date only.
  • Leaves the remediation work to the internal team, untracked.
Valentra

A risk analysis you operate

  • Runs inside the Managed Security Program on Valentra Nexus.
  • Updates as assets, risks, and controls change.
  • Carries the remediation work and its evidence in the same record.
Consequence

What a stale analysis costs

  • Audit exposure

    When evidence and policy have drifted apart, an auditor finds the gap before you do.

  • Board blind spots

    Leadership approves a posture that was true last quarter, not today.

  • Unowned remediation

    Findings are documented, then left to a team with no operating record to work from.

  • Repeated rediscovery

    Each new assessment re-learns the environment instead of building on the last.

Impact

The first thirty days

  1. Days 1–10 Discover
    • Valentra Nexus inventories the assets and systems in scope.
    • Each identified risk is ranked and tied to a candidate control.
  2. Days 11–20 Operate
    • Controls are activated and their evidence is collected in one record.
    • Open risks are assigned owners and remediation work begins.
  3. Days 21–30 Report
    • The first Decision Packet summarizes posture and open risk.
    • Leadership reviews a current, defensible risk analysis.

Built for the committee that owns the decision

This speaks most to

The board-ready Decision Packet this produces

Every Valentra Labs program produces the same artifact: a board-ready Decision Packet carrying the situation, options, recommendation, evidence, and approval chain — generated by Valentra Nexus.

Decision Packet · v1.0

Q2 2026 — Crown-Jewel Risk Disposition

pkt_2026-04-17_a3f8e1

Situation

Q2 program review covers the crown-jewel ePHI store and its supporting control envelope. 487 endpoints catalogued across three network segments; 12 unsanctioned SaaS surfaces detected by the shadow-IT scan. Continuous monitoring posture is operating; the residual question is risk acceptance for two compensating-control gaps surfaced this cycle.

Risk & Impact

14 critical findings scored against the revenue-at-risk model. Two compensating gaps (vendor-SOC-2 attestation lapse + patch-cycle #38 awaiting CAB sign-off) carry residual risk of $1.4M in unmitigated regulatory exposure if a HITRUST audit lands before remediation closes. Patient-data confidentiality remains the load-bearing impact dimension.

Options

  1. Accept residual risk through Q3, with quarterly board re-review.
  2. Accelerate remediation by re-prioritizing the patch cycle ahead of the planned Q3 platform migration (cost: 2 engineer-weeks).
  3. Transfer risk via expanded cyber-insurance rider (cost: $48K/yr premium delta; coverage gap on ePHI exfiltration remains).

Recommendation

Pursue Option 2 — accelerate remediation. The 2 engineer-weeks of effort cost is recoverable in Q3; the residual exposure is asymmetric (regulatory floor of $1.4M vs. ~$120K labor delta). Document the patch-cycle re-prioritization as a logged decision with the program owner; close the SOC-2 attestation gap via vendor outreach in the same window. Insurance rider deferred to Q4 review.

Evidence

Twelve evidence artifacts back the recommendation — asset inventory, control mapping, vendor SOC-2 status, residual-risk model, patch-cycle telemetry, and the prior packet's audit trail. One control attestation is overridden with a documented compensating-control narrative; two vendor attestations are pending the Q2 refresh window.
ArtifactHashStatusDetailCaptured
Asset inventory snapshot — 487 endpoints#a3f8e1b2verified—
Control mapping cross-walk — 93 controls#b7c4d9e0verified—
Vendor SOC-2 attestation — current#c9d0e2f1pendingRefresh window opens 2026-05-12; vendor confirmed window…
Vendor SOC-2 attestation — secondary processor#d2e3f4a5pending—
Residual-risk model — revenue-at-risk#e1f2a3b4verified—
Patch cycle #38 — CAB queue position#f3a4b5c6overridden—
Overridden per compensating-control narrative — see attached
Penetration test report — Q1 follow-up#a5b6c7d8stale—
Prior packet audit trail — pkt_2026-01-09_b8c4e2#b6c7d8e9verified—

Approval Chain

CIO and CISO have signed. The CCO signature is pending receipt of the vendor-SOC-2 refresh; the program owner has logged the override and the compensating-control narrative.
  1. Chief Information OfficerM. AlvarezSigned 2026-04-17T14:08:11Z
  2. Chief Information Security OfficerJ. ParkSigned 2026-04-17T14:18:42Z
  3. Chief Compliance Officer—Pending signatureAwaiting vendor SOC-2 refresh — window opens 2026-05-12
Generated by Valentra Nexuspkt_2026-04-17_a3f8e1
In practice

From a signed PDF to a live record.

Illustrative · not a specific customer Discuss how this applies to your environment.
Before
  • Annual risk analysis delivered as a 40-page PDF.
  • Remediation tracked in a spreadsheet nobody owned.
  • No answer when the board asked what changed since last year.
After Valentra
  • Risk analysis operated continuously on Valentra Nexus.
  • Every risk tied to a control and its evidence.
  • A Decision Packet answers “what changed” in one view.
FAQ

The questions we hear most.

Is this a one-time assessment or an ongoing program?

It is an ongoing program. Valentra Labs operates the HIPAA Security Rule risk analysis continuously inside the Managed Security Program, so the analysis stays current between reviews.

How does this map to §164.308(a)(1)(ii)(A)?

The risk analysis implementation specification requires an accurate, thorough assessment of the risks to electronic protected health information. Valentra Nexus records each risk, its likelihood and impact, and the control that treats it, so the assessment is documented and maintained in one record.

Do you replace our existing security tools?

No. Valentra Nexus operates above the tools you already run, tying their signals to the risks and controls in your program rather than replacing them.

Who owns the remediation work?

Valentra Labs operates the program and tracks each remediation item to its control and its evidence. Your team stays informed through the Decision Packet rather than managing a separate tracker.

Program Assessment See How Valentra Works

Valentra Labs runs the HIPAA Security Rule risk analysis as a continuous program: Valentra Nexus discovers assets, ranks risk, ties each risk to a control and its evidence, and produces a board-ready Decision Packet — one operating record, not a once-a-year spreadsheet.

as of HIPAA Security Rule §164.308(a)(1)(ii)(A)